Skip to content
Cardiovascular healthResearch article3 min read

Swedish reference values for VO2max estimated by two submaximal cycle tests

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Reference values for estimated VO_(2)max by two submaximal cycle tests: the Åstrand-test and the Ekblom-Bak test. · European journal of applied physiology · 2024 · Original paper ↗

Key takeaway

Using health assessments of 263,374 Swedish adults aged 20-69 for the Åstrand test and 95,043 for the Ekblom-Bak test, the authors built age- and sex-specific percentile reference values for estimated VO2max. These come from two specific cycle tests, each with its own bias, so they are only meaningful for comparing a result from the same test.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Submaximal tests estimate VO2max from a test that stops short of maximal effort, and each test has inherent biases, so a result only means something against references built on the same test. The authors set out to create sex- and age-specific reference values for the Åstrand and Ekblom-Bak cycle tests and to see how age, exercise level and BMI affect the estimates.

Who and how

Observational study of men and women aged 20-69 years from the Swedish working population who took part in Health Profile Assessments between 2010 and 2020. After excluding smokers and people taking heart-rate-affecting medicines, 263,374 people were included for the Åstrand test (Å-test) and 95,043 for the Ekblom-Bak test (EB-test). Reference values were set at the 10th, 25th, 40th, 60th, 75th and 90th percentiles for each sex across 5-year age groups, and the effects of age, exercise level and BMI were assessed.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    In men, estimated absolute and relative VO2max were 3.11 L/min and 36.9 mL/min/kg with the Å-test, and 3.58 L/min and 42.4 mL/min/kg with the EB-test.
  2. 2
    In women, they were 2.48 L/min and 36.6 mL/min/kg with the Å-test, and 2.41 L/min and 35.5 mL/min/kg with the EB-test. The abstract does not say whether these are means or medians.
  3. 3
    Higher age and higher BMI were associated with lower estimated VO2max, and a higher exercise level with higher estimated VO2max, in both tests.
  4. 4
    Exercise level explained little of the variation in estimated VO2max (10% for the Å-test, 8% for the EB-test), while BMI explained a moderate share (23% and 29%).

Limits & uncertainty

  1. 1
    The values are estimates from submaximal tests, not measured VO2max, and the abstract itself notes that each test carries its own bias.
  2. 2
    Participants were working-age Swedes attending workplace Health Profile Assessments, with smokers and people on heart-rate-affecting medicines excluded, so the references may not describe the wider population or those groups.
  3. 3
    The percentile tables themselves are not in the abstract, and it does not say how exercise level was measured. This reading is based on the abstract only.

What to take from it

If you have done an Åstrand or Ekblom-Bak cycle test, these age- and sex-specific percentiles let you see where your result sits, as long as you use the table for the matching test. Results from the two tests, or from other methods, should not be mixed. A low rank is a reason to talk with a clinician or trainer, not a diagnosis.

Reading your own data

Wearable VO2max estimates are not the Åstrand or Ekblom-Bak test, so these tables cannot be applied directly to a watch number. Use your watch estimate to follow your own trend on the same device, and expect age, training and body weight (BMI) to move it, as they moved the estimates here. If a clinic or workplace gave you a cycle test, repeat the same test to compare.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Aims

Submaximal tests estimating VO_(2)max have inherent biases; hence, using VO_(2)max estimations from the same test is essential for reducing this bias. This study aimed to establish sex- and age-specific reference values for estimated VO_(2)max using the Åstrand-test (Å-test) and the Ekblom-Bak test (EB-test). We also assessed the effects of age, exercise level, and BMI on VO_(2)max estimations.

Methods

We included men and women (20-69 years) from the Swedish working population participating in Health Profile Assessments between 2010 and 2020. Excluding those on heart rate-affecting medicines and smokers, n = 263,374 for the Å-test and n = 95,043 for the EB-test were included. VO_(2)max reference values were based on percentiles 10, 25, 40, 60, 75, and 90 for both sexes across 5-year age groups.

Results

Estimated absolute and relative VO_(2)max were for men 3.11 L/min and 36.9 mL/min/kg using the Å-test, and 3.58 L/min and 42.4 mL/min/kg using the EB-test. For women, estimated absolute and relative VO_(2)max were 2.48 L/min and 36.6 mL/min/kg using the Å-test, and 2.41 L/min and 35.5 mL/min/kg using the EB-test. Higher age (negative), higher exercise level (positive), and higher BMI (negative) were associated with estimated VO_(2)max using both tests. However, explained variance by exercise on estimated VO_(2)max was low, 10% for the Å-test and 8% for the EB-test, and moderate for BMI, 23% and 29%.

Conclusion

We present reference values for estimated VO_(2)max from two submaximal cycle tests. Age, exercise, and BMI influenced estimated VO_(2)max. These references can be valuable in clinical evaluations using the same submaximal tests.

Sources & attribution

Reference values for estimated VO_(2)max by two submaximal cycle tests: the Åstrand-test and the Ekblom-Bak test.

Väisänen D, Ekblom B, Wallin P, Andersson G, Ekblom-Bak E.

European journal of applied physiology · 2024-01-22

DOI: 10.1007/s00421-023-05398-8 ↗PubMed · 38252302 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →